Showing results (251-260 of 657) with videos related to
Sort By:
Pageof 66
Biology of Reproduction|May 27, 2005
Gonadotropin control of inhibin secretion and the relationship to follicle type and number in the hpg mouseYuan Wang, Helen Newton, Jenny A Spaliviero, et al.The Journal of Endocrinology|May 17, 2013
Evidence for increased tissue androgen sensitivity in neurturin knockout miceUlla Simanainen, Yan Ru Ellen Gao, Reena Desai, et al.Trends in Endocrinology and Metabolism: TEM|September 10, 2018
New Perspectives on the Pathogenesis of PCOS: Neuroendocrine OriginsKirsty A Walters, Robert B Gilchrist, William L Ledger, et al.Frontiers in Endocrinology|August 21, 2019
<i>In-utero</i> Exposure to Maternal Stressful Life Events and Risk of Cryptorchidism: The Raine StudyElvira V Bräuner, Martha Hickey, Åse Marie Hansen, et al.Clinical Endocrinology|November 7, 2009
Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient menCarolyn Fennell, Gideon Sartorius, Lam P Ly, et al.Maturitas|December 22, 2005
Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic womenRoger E Peverill, Joseph J Smolich, Erica Malan, et al.Menopause (New York, N.Y.)|January 17, 2023
Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studiesChandima Hemachandra, Susan R Davis, Robin J Bell, et al.Menopause (New York, N.Y.)|March 13, 2014
Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosisSusan R Davis, Mary Panjari, Penelope J Robinson, et al.Journal of Geriatric Oncology|February 6, 2014
A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70+ with those aged <70 years at the time of diagnosis of breast cancerMary Panjari, Penelope J Robinson, Susan R Davis, et al.Menopause (New York, N.Y.)|June 25, 2013
Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosisRobin J Bell, Max Schwarz, Pamela Fradkin, et al.Pageof 66